SIAS
ALXN

Shine Investment Advisory Services’s Alexion Pharmaceuticals ALXN Stock Holding History

Shine Investment Advisory Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-366
Closed -$40K – 797
2019
Q4 		$40K Sell
366
-318
-46% -$34K 0.02% 366
2019
Q3 		$67K Sell
684
-213
-24% -$24K 0.03% 255
2019
Q2 		$117K Hold
897
– – 0.05% 156
2019
Q1 		$121K Hold
897
– – 0.06% 157
2018
Q4 		$87K Buy
897
+478
+114% +$56.5K 0.04% 191
2018
Q3 		$58K Hold
419
– – 0.03% 275
2018
Q2 		$52K Hold
419
– – 0.03% 308
2018
Q1 		$47K Hold
419
– – 0.03% 318
2017
Q4 		$50K Buy
+419
New +$51K 0.02% 311

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Shine Investment Advisory Services's ALXN Position: Q1 2020 in Review

Shine Investment Advisory Services sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 366 shares — an estimated $40K sold.

Shine Investment Advisory Services first reported a position in ALXN in Q4 2017 and held it in 9 quarters. The position peaked at $121K in Q1 2019. 653 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Shine Investment Advisory Services reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Shine Investment Advisory Services sold 366 Alexion Pharmaceuticals shares in Q1 2020, an estimated $40K.
  • Shine Investment Advisory Services first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 9 quarters.
  • Shine Investment Advisory Services's Alexion Pharmaceuticals position peaked at $121K in Q1 2019.
  • 653 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Shine Investment Advisory Services's 13F filing for Q1 2020, filed 27 Apr 2020.